Atlas Trials

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients

Clinical trial NCT00347503 · COMPLETED

Trial details

NCT number
NCT00347503
Sponsor
Innovative Medical
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cataract

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.